Xcout Intel
Marius Pharmaceuticals, LLC
Marius Pharmaceuticals, LLC develops hormone health therapies focused on testosterone deficiency and metabolic vitality. The company offers KYZATREX, an oral prescription drug used to treat adult men with low or no testosterone levels due to specific medical conditions.
Subscribe to see Marius Pharmaceuticals, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Marius Pharmaceuticals, LLC at a glance
Marius Pharmaceuticals, LLC is a biotechnology & pharmaceuticals company headquartered in United States. It has raised at least $25.6M across the 2 funding rounds on record. Its most recent funding round raised $20M in June 2019. Xcout tracks 8 named people at Marius Pharmaceuticals, LLC, including Shalin Y. Shah (Chief Executive Officer).
Marius Pharmaceuticals, LLC leadership
- Shalin Y. ShahChief Executive Officer
- Amit ShahBoard Director / Chief Operations Officer
- Himanshu H. ShahExecutive Chairman / Founder
- Greg ThomasSenior VP of Marketing & Corporate Accounts
- Polly SawyerSenior VP of Commercial Development
- Rich CallaghanSenior VP of Operations
2 more named people on record for Marius Pharmaceuticals, LLC, with roles, board committees and tenure — see the full roster →
Marius Pharmaceuticals, LLC funding rounds
At least $25.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $5.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Marius Pharmaceuticals, LLC competitors
A few of Marius Pharmaceuticals, LLC's closest competitors — see the full list of competitors and alternatives →
Clarus Therapeutics is a U.S. specialty pharmaceutical company focused on men’s health and testosterone replacement therapy. It developed JATENZO (testosterone undecanoate), an oral testosterone replacement treatment for adult men with hypogonadism associated with a medical condition.
Acrux Limited and its associated entities specialize in the development and commercialization of generic and topically applied pharmaceutical products. Their global operations span Australia, Europe, the United States, and various other international markets. The company provides a comprehensive range of testosterone therapies for adult males experiencing insufficient or absent testosterone levels, including oral and buccal tablets, subcutaneous pellets, transdermal patches, injectable formulations, and topical gels. Furthermore, Acrux offers estradiol sprays, specifically marketed under the brand names Evamist and Lenzetto, to women for the management of hot flashes associated with menopause. Established in 1998, the firm's headquarters are located in West Melbourne, Australia.
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Innovus Pharmaceuticals, Inc. offers science-backed dietary supplements and wellness products designed to support everyday health and active adults. The company provides modern healthcare solutions utilizing proven active ingredients to help customers manage various health needs.
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company that develops and markets cortisol modulation therapies to treat serious medical conditions. The company focuses on modulating cortisol activity at the glucocorticoid receptor to create novel treatments across therapeutic areas such as endocrinology, oncology, metabolism, and neurology.
Endo Medical provides pharmaceutical products and scientific medical information resources for healthcare professionals in the United States. The company distributes medications spanning various therapeutic areas, including endocrinology, urology, pain management, and specialized therapies, while offering tools to submit medical inquiries and report adverse events.
Get Marius Pharmaceuticals, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Marius Pharmaceuticals, LLC in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access